VirExit Technologies (VXIT) Stock Continues to Fall: Down 40% in a Week

VirExit Technologies Inc. (OTCMKTS:VXIT) plunged 19% after the company announced the addition of Dr. Michael Lewis, MD, to its Advisory Board. He will be a crucial addition to the VirExit team owing to his leadership and tremendous experience in patient care, frontier sciences, and integrative health.  Dr. Lewis’s experience will be vital in the company’s launch of education wellness and health portal where he will help in content product reviews and whole health approach. Equally, he will be responsible for helping populate the SaferPlace Market with curated health, wellness, and safety products.

The company’s CEO, James C. Katzaroff, said that Dr. Lewis’ decades of Preventive Medicine experience and board certification would allow him to add to VirExit’s perspective during this critical time of growth. Katzaroff said that VirExit is a company that can understand the importance of organizations’ and employees’ well-being and consumers.’

Currently, VirExit’s team of professionals, including its top health advisors, are evaluating various educational content and other products to be onboarded regularly. In the coming months, VirExit is a stock to watch.

Market Reaction:

On Thursday, VXIT stock fell 19.37% to $0.0115 with more than 60.80 million shares, compared to  its average volume of 40.40 million shares. The stock has moved within a range of $0.0111 – 0.0143 after opening the trade at $0.0142. Over the past 52-week, the stock has been trading within a range of $0.0005 – 0.1200.

Related Posts

About The Author